-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Xinlitai (002294.SZ) announced that the company received the “Clinical Trial Approval Notice” approved and issued by the State Drug Administration and agreed to carry out clinical trials of the innovative small molecule drug SAL0137 tablets (project code: SAL0137) independently developed by the company to treat increased lipoprotein (a).

Zhitongcaijing·12/19/2025 09:41:13
Listen to the news
Zhitong Finance App News, Xinlitai (002294.SZ) announced that the company received the “Clinical Trial Approval Notice” approved and issued by the State Drug Administration and agreed to carry out clinical trials of the innovative small molecule drug SAL0137 tablets (project code: SAL0137) independently developed by the company to treat increased lipoprotein (a).